Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Harvard Business School
Farmers Insurance
AstraZeneca
Teva
QuintilesIMS

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,744,138

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,744,138
Title:Treatment method and product for uterine fibroids using purified collagenase
Abstract: The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
Inventor(s): Leppert; Phyllis Carolyn (Salt Lake City, UT), Wegman; Thomas L. (N. Merrick, NY), Taylor; Darlene K. (Burlington, NC)
Assignee: BioSpecifics Technologies Corp. (Lynbrook, NY) Duke University (Durham, NC) North Carolina Central University (Durham, NC)
Application Number:14/213,910
Patent Claims:see list of patent claims

Details for Patent 9,744,138

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Try a Free Trial BioSpecifics Technologies Corp. (Lynbrook, NY) Duke University (Durham, NC) North Carolina Central University (Durham, NC) 2033-03-15 RX search
Auxilium Pharms XIAFLEX collagenase clostridium histolyticum SOLUTION; INJECTION 125338 001 2010-02-02   Try a Free Trial BioSpecifics Technologies Corp. (Lynbrook, NY) Duke University (Durham, NC) North Carolina Central University (Durham, NC) 2033-03-15 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Daiichi Sankyo
McKesson
QuintilesIMS
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.